Shivanu Dhawan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 259 1st St Rm 291, Mineola, NY 11501 Phone: 516-663-8963 Fax: 516-663-8964 |
Elise Kochoumian, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-8963 Fax: 516-663-8964 |
Daniel Jason Garcia, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-8963 Fax: 516-663-8964 |
Vrajen Vora, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-8963 |
Dr. Lisa N Persaud, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 222 Station Plz N, Suite 310, Mineola, NY 11501 Phone: 516-663-3822 |
Sabina Maria Constantine, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 222 Station Plz N, Suite 310, Mineola, NY 11501 Phone: 516-663-8963 |
Niyati Ajit Bhagwat, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: Nyu Winthrop Hospital, 259 1st Street, Mineola, NY 11501 Phone: 516-663-0333 |
Dr. Mariele Hall, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 222 Station Plz N Ste 509, Mineola, NY 11501 Phone: 516-663-2381 |
Odette Thomas, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-8963 Fax: 516-663-8964 |
Erica Visconti-ferrara, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Mineola, Mineola, NY 11501 Phone: 516-663-8693 Fax: 516-663-8964 |
Sharmin Asha, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-8963 Fax: 516-663-8964 |
Dr. Jeffrey T Samuel, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-8963 |
Dr. Daniel Caesar Kazmierski, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-8963 Fax: 516-663-8964 |
Sun Woo Hong, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 222 Station Plz N Ste 509, Mineola, NY 11501 Phone: 516-663-2381 Fax: 516-663-8796 |
Mr. Aaron Thomas Damato, Hospitalist Medicare: Medicare Enrolled Practice Location: 259 1st St, Mineola, NY 11501 Phone: 866-946-8476 |
Dr. Zaki Yousuf Azam, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-8963 |
Connie Chen, Hospitalist Medicare: Medicare Enrolled Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-8963 Fax: 516-663-8964 |
Angela Buonvino, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Winthrop 2 Room 291, Mineola, NY 11501 Phone: 515-663-8693 Fax: 516-663-8964 |
Jason Ford, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-8963 Fax: 516-663-8964 |
Andrew Valenti, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 259 1st St, Mineola, NY 11501 Phone: 516-663-8963 Fax: 516-663-8964 |
News Archive
A team of Princeton University scientists has produced a systematic listing of the ways a particular cancerous cell has "gone wrong," giving researchers a powerful tool that eventually could make possible new, more targeted therapies for patients.
In a new paper, researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) report brain chemistry that may contribute to why drinkers have difficulty paying attention while under the influence.
The National Patient Advocate Foundation (NPAF) - a national, non-profit organization dedicated to the mission of creating avenues of improved patient access to health care through public policy reform at the state and federal levels - today released "Must Have Provisions Under Health Reform," an independent analysis of proposed insurance market reforms and their role in improving the current health care system.
Genmab A/S announced today encouraging results from an ofatumumab Phase II safety and pharmacokinetics study in patients with relapsing-remitting multiple sclerosis (RRMS).
› Verified 4 days ago